Foot and Mouth Disease Vaccine Market - Global forecast, 2022 - 2028

Foot and Mouth Disease Vaccine Market - Global forecast, 2022 - 2028

Foot and Mouth Disease (FMD) is infectious disease, which majorly affects cattle, sheep, goats and swine. It is highly prevalent in regions such as Asia pacific, Latin America, Africa, Middle East and Eastern Europe. Foot and mouth diseases are gaining significant traction due to its economic impact on food industry, as it affects milk and meat production. Therefore, FMD vaccine play important role in the prevention of disease. Both oil-based and aluminum hydroxide adjuvants variety are available. However, oil-based vaccine hold dominant position in the FMD vaccine market
Market Dynamics
Outbreak of the foot and mouth disease and associated economic loses are important driver for the growth of the FMD vaccine market. According to World Organization for Animal Health (OIE), around 23 countries from Asia Pacific, Latin America and Africa reported FMD outbreak in the 2016. According to journal Acta Tropica published in May 2021, prevalence of FMD in Ethiopia ranges from 5.6% to 42.7% in cattle and from 4% to 11% in small ruminant and in 30% in ungulate wildlife. Five of seven serotypes, namely serotype O, A, C, SAT1 and SAT2 are most commonly observed. This hampers animal rearing and trade practice at significant extent. Government initiatives to combat FMD outbreak would be another important driver for growth of FMD vaccine market. In March, 2007, Argentina, Brazil, and Paraguay government committed to intensive vigilance for FMD in a shared zone encompassing a small area along both sides of their common borders. The agreement became effective due to joint evaluation mission by OIE
Key features of the study:

This report provides in-depth analysis of the foot and mouth disease vaccine market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global foot and mouth disease vaccine market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Indian Immunologicals Ltd., Agrovet, MSD Animal Health, Vallee SA, Bayer HealthCare, Brilliant Bio Pharma Ltd., Intervet, Biovet, Merial, China Animal Husbandry Co., Ltd., Biogénesis-Bagó S.A, Vetal Animal Health Products, S.A.VETAL Animal Health Products, and Vecol S.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global foot and mouth disease vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global foot and mouth disease vaccine market

Detailed Segmentation:
Global Foot and Mouth Disease Vaccine Market, By Vaccine Type

Conventional Vaccine
Aluminum Hydroxide based vaccine
Oil based vaccines
Emergency Vaccines

Global Foot and Mouth Disease Vaccine Market, By Animal Type

Cattle
Sheep and Goat
Swine
Others

Global Foot and Mouth Disease Vaccine Market, By Geography

North America

By Vaccine Type:

Conventional Vaccine
Aluminum Hydroxide based vaccine
Oil based vaccines
Emergency Vaccines

By Animal Type:

Cattle
Sheep and Goat
Swine
Others

By Country:

U.S.
Canada

Latin America

By Vaccine Type:

Conventional Vaccine
Aluminum Hydroxide based vaccine
Oil based vaccines
Emergency Vaccines

By Animal Type:

Cattle
Sheep and Goat
Swine
Others

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

Europe

By Vaccine Type:

Conventional Vaccine
Aluminum Hydroxide based vaccine
Oil based vaccines
Emergency Vaccines

By Animal Type:

Cattle
Sheep and Goat
Swine
Others

By Country:

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific

By Vaccine Type:

Conventional Vaccine
Aluminum Hydroxide based vaccine
Oil based vaccines
Emergency Vaccines

By Animal Type:

Cattle
Sheep and Goat
Swine
Others

By Country:

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East

By Vaccine Type:

Conventional Vaccine
Aluminum Hydroxide based vaccine
Oil based vaccines
Emergency Vaccines

By Animal Type:

Cattle
Sheep and Goat
Swine
Others

By Country:

GCC
Israel
Rest of Middle East

Africa

By Vaccine Type:

Conventional Vaccine
Aluminum Hydroxide based vaccine
Oil based vaccines
Emergency Vaccines

By Animal Type:

Cattle
Sheep and Goat
Swine
Others

By Country:

South Africa
Central Africa
North Africa

Company Profiles

Agrovet*

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies

India Immunologicals Ltd.
Merck Animal Health
Shanghai Hile Bio-Pharmaceutical Co., Ltd.
Vallee SA
Brilliant Bio Pharma Ltd
Merial
China Animal Husbandry Co., Ltd.
Biogénesis-Bagó S.A.
Vetal Animal Health Products S.A.

“*” marked represents similar segmentation in other categories in the respective section.